Rush Hymenoptera venom immunotherapy: Successful treatment in a patient with systemic mast cell disease
- 30 September 1994
- journal article
- case report
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 94 (3) , 556-559
- https://doi.org/10.1016/0091-6749(94)90213-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Reduction of side effects from rush‐immunotherapy with honey bee venom by pretreatment with terfenadineClinical and Experimental Allergy, 1992
- Pediatric MastocytosisJournal of Investigative Dermatology, 1991
- ConclusionsJournal of Investigative Dermatology, 1991
- Analysis of plasma histamine levels in patients with mast cell disordersThe American Journal of Medicine, 1989
- Analysis of the wheal-and-flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosisJournal of Allergy and Clinical Immunology, 1989
- Systemic Mast Cell DiseaseMedicine, 1988
- A survey of the number and distribution of mast cells in the skin of patients with mast cell disordersJournal of Allergy and Clinical Immunology, 1988
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisNew England Journal of Medicine, 1987
- The Ige and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regiments of venom immunotherapyJournal of Allergy and Clinical Immunology, 1985
- Clustered Immunotherapy with Yellow Jacket VenomAllergy, 1985